• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home Uncategorized

Inhibition of molecular signaling in injured cornea hastens cell migration and wound closure

bys25qthea
November 14, 2012
in Uncategorized
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

Key study points:

1. Decreased Notch signaling increases the migratory capacity, but not proliferation, of corneal epithelial cells and improves healing of corneal wounds.

2. Inhibition of Notch signaling allows actin cytoskeletal changes that may favor migration, thus providing a possible mechanism for promotion of corneal wound closure.

Primer: The cornea is essential to allowing passage of light into the eye, acting as the “window” for light to reach the retina. The corneal epithelium is vital, as its main function is protection of the cornea from bacterial, viral, and fungal pathogens. Trauma to the cornea, such as a scratch, leads to a breach of the epithelium, and thus increases the risk of subsequent infection; the longer the breach exists, the greater the risk. When the epithelium is injured, remaining epithelial cells attempt to correct the defect rapidly, hypothesized to occur by proliferation and differentiation. The Notch molecular pathway is a  appears to be essential to this process. When activated, the Notch intracellular fragment translocates to the nucleus to activate target genes.

The authors previously reported a downregulation of Notch1 during the beginning stages of wound healing in the corneal epithelium, which they thought corresponded to an increase in epithelial proliferative capacity.

RELATED REPORTS

Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective

Medicaid-reimbursed weight-loss GLP-1 prescriptions fell after coverage withdrawal in 4 states

Background reading:

1. Djalilian AR, Namavari A, Ito A, et al. Down-regulation of Notch signaling during corneal epithelial proliferation. Mol Vis. 2008;14:1041–1049.

2. H, Lu Q, Zheng Y, Li Q. Notch signaling promotes the corneal epithelium wound healing. Mol Vis. 2012;18:403–411.

This [in vitro] study: The study involved several components:

1. Inhibition of Notch signaling was induced in human corneal epithelial cells, both via exposure to DAPT, a Notch inhibitor, and via knockout of the Notch1 gene using stable transfection with Notch1-shorthairpin RNA (shRNA). Capacity for epithelial healing was subsequently assessed in the two inhibited cells and in control cells (treated with DMSO) using an injury model. The authors assessed the epithelial cells’ ability to migrate and proliferate using cell plating and proliferation assays (optical densitometry and immunofluorescence (IF) of Ki67, a proliferation marker), respectively.

2. IF for the cytoskeletal protein phalloidin was completed to assess for effect of Notch inhibition on the cell cytoskeleton.

3. Corneal wound healing was studied in the in vivo setting using mice. Mouse corneas were scratched, DAPT or DMSO was administered, and subsequent fluorescein staining revealed the rate of wound closure.

Notch1 expression was significantly reduced (42% of baseline expression) at the leading edge of the migrating corneal epithelium during the healing process. Inhibition of Notch1 using DAPT encouraged wound closure in the scratch assay and DAPT-treated cells exhibited a significant increase in migration of approximately 2.2-fold over control cells (p<0.0001). Similarly, cells transfected with the Notch1 shRNA exhibited faster closure of scratch wounds (p<0.004) and increased cell migration of approximately 4-fold greater than control cells. Studies using IF staining for phalloidin found that Notch inhibition reduced cell-matrix adhesion by 35%. However, Notch inhibition did not appear to alter cell proliferation. Finally, in mice that underwent corneal trauma, DAPT treatment demonstrated a higher percentage area of wound closure (p=0.025) compared to controls treated with DMSO.

In sum: Inhibition of the Notch pathway, either by direct inhibition using DAPT or Notch1 knockout using shRNA, results in a pro-migratory phase for corneal epithelium especially near the leading edge. Inhibition of cell-matrix adhesion may be a plausible mechanism by which this progression is occurring. These findings suggest that Notch inhibition may prove to be a promising future research direction in the development of clinical interventions for corneal epithelium healing.

Strengths of this study include the use of multiple assays to survey the Notch pathway, as well as the in vivo data that provides a clinical connection. This study faces a couple of important limitations. First, given the widespread importance of the Notch pathway and its prevalence in cell signaling; the direct application of a Notch inhibitor to the eye may have widespread side effects in the clinical setting, thus reducing the applicability of this study. In addition, previous studies have identified that the degree to which Notch pathways are activated can have significantly different effects; it is a highly dose-dependent relationship. However, the authors did not quantify the degree of Notch inhibition, which would have provided more information regarding the level at which Notch inhibition may promote epithelial healing in the cornea.

Click to read the study in IOVS

By [SSS] and [MK]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

[Physician Comment] Dr. Jahan Fahimi M.D., M.P.H., talks about the issue of CT scan usage in children and suggests useful guidelines for practitioners

Next Post

Treating displaced femoral neck fractures: total hip arthroplasty (THA) found superior to open-reduction internal fixation (ORIF)

RelatedReports

Lung cancer immunotherapy collage: engraved lungs and trachea, a cluster of round immune cells and a folded surgical towel
Cardiology

Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective

November 19, 2026
GLP-1 medicines and aging collage: a smiling white-haired man with a mustache beside a bonsai tree and a capped injection pen
All Specialties

Medicaid-reimbursed weight-loss GLP-1 prescriptions fell after coverage withdrawal in 4 states

November 18, 2026
Aging collage: a smiling older man beside an hourglass, folded reading glasses and a pair of walking shoes
Chronic Disease

Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults

November 18, 2026
A sleeping teenager depicted in bed with a clock and graphics illustrating growth patterns, highlighting the importance of sleep for adolescent growth and health.
Artificial Intelligence

Gait analysis predicts health, sleep, and medication use across 18 body systems

November 18, 2026
Next Post

Treating displaced femoral neck fractures: total hip arthroplasty (THA) found superior to open-reduction internal fixation (ORIF)

[In The News] Modest protection conferred by malaria vaccine in phase 3 trial

New approach may enhance the effectiveness of hyperthermic chemotherapy for peritoneal metastatic cancer

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective
  • Medicaid-reimbursed weight-loss GLP-1 prescriptions fell after coverage withdrawal in 4 states
  • Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.